O'Dwyer's reports on merger of INC Research and inVentiv Health.
In the article, Michael Bell, Executive Chairman of the Board; President, Commercial Division, is quoted as saying - “By coming together with INC Research, we’ll be able to infuse our best-in-class communications solutions earlier into the clinical development process... One example is our ability to leverage our communications and behavioral analysis expertise to streamline the clinical trial recruitment process. We’re able to reach the right patients quickly and communicate with them effectively, speeding up trial enrollment and the eventual delivery of therapies to those that need them the most.”
Read more by clicking the link below.
This content is repurposed from odwyerpr.com.